Substituted amide beta secretase inhibitors
View Patent ↗Disclosed are novel compounds of the formula or a pharmaceutically acceptable salt or solvate thereof, wherein R 1 , R 2 , R 3 , R 4 and X are as defined in the specification. Also disclosed are pharmaceutical compositions comprising the compounds of formula I. Also disclosed are methods of treating cognitive or neurodegenerative diseases such as Alzheimer's disease. Also disclosed are methods of treating a cognitive or neurodegenerative disease comprising administering to a patient I need of such treatment a combination of at least one compound of formula I and at least one compound selected from the group consisting of β-secretase inhibitors other than those of formula I, HMG-CoA reductase inhibitors, gamma-secretase inhibitors, non-steroidal anti-inflammatory agents, N-methyl-D-aspartate receptor antagonists, cholinesterase inhibitors and anti-amyloid antibodies.
1. A compound having the structural formula
or a pharmaceutically acceptable salt thereof, wherein
R 2 is hydrogen or alkyl;
R 3 is phenylene;
R 4 is —C(O)-alkyl, —C(O)Oethyl, alkyl, cycloalkyl, cycloalkylalkyl, aryl, aralkyl, alkoxyalkyl, heterocyclyl, heterocyclylalkyl, heteroaralkyl or heteroaryl;
R 6 is
each R 7 is independently selected from hydrogen, —OH, alkyl, cycloalkyl, aryl, heteroaryl, aralkyl, heteroaralkyl, aralkoxy, heteroaralkoxy and alkoxy; and
X is a bond connecting R 3 and R 4 ,
or, alternatively, X is —O—, —S—, alkylene, -alkyleneNH—, -alkyleneNHC(O)—, -alkyleneNHSO 2 —, —NH—, —NHC(O)—, or —NHSO 2 —;
wherein each alkyl is optionally substituted with 1 to 3 moieties selected from the group consisting of halo, alkyl, aryl, cycloalkyl, cyano, hydroxy, alkoxy, alkylthio, amino, —NH(alkyl), —NH(cycloalkyl), —N(alkyl) 2 , carboxy and —C(O)O-alkyl; and
wherein each phenylene, heterocyclylalkyl, cycloalkyl, cycloalkylalkyl, aryl, heteroaryl, heterocyclyl, aralkyl, heteroaralkyl, aralkoxy or heteroaralkoxy is optionally substituted with 1 to 4 moieties selected from the group consisting of —CF 3 , alkyl, alkenyl, alkynyl, aryl, heteroaryl, aralkyl, alkylaryl, heteroaralkyl, arylalkenyl, heteroarylalkenyl, arylalkynyl, heteroarylalkynyl, alkylheteroaryl, hydroxy, hydroxyalkyl, alkoxy, aryloxy, aralkoxy, acyl, aroyl, halo, nitro, cyano, carboxy, alkoxycarbonyl, aryloxycarbonyl, aralkoxycarbonyl, alkylsulfonyl, arylsulfonyl, heteroarylsulfonyl, alkylthio, arylthio, heteroarylthio, aralkylthio, heteroaralkylthio, cycloalkyl, heterocyclyl, —C(═N—CN)—NH 2 , —C(═NH)—NH 2 , —C(═NH)—NH(alkyl), Y 1 Y 2 N—, Y 1 Y 2 NC(O)—, Y 1 Y 2 NSO 2 — and —SO 2 NY 1 Y 2 , wherein Y 1 and Y 2 can be the same or different and are independently selected from the group consisting of hydrogen, alkyl, aryl, cycloalkyl, —C(O)alkyl and aralkyl, with the proviso that cycloalkyl, cycloalkylene, heterocyclyl and heterocyclylene can be substituted with ═O,
wherein:
“heteroaryl” means a moiety selected from pyridyl, pyrazinyl, furanyl, thienyl, pyrimidinyl, isoxazolyl, isothiazolyl, oxazolyl, thiazolyl, pyrazolyl, furazanyl, pyrrolyl, pyrazolyl, triazolyl, 1,2,4-thiadiazolyl, pyrazinyl, pyridazinyl, quinoxatinyl, phthalazinyl, imidazo[1,2-a]pyridinyl, imidazo[2,1-b]thiazolyl, benzofurazanyl, indolyl, azaindolyl, benzimidazolyl, benzothienyl, quinolinyl, imidazolyl, thienopyridyl, quinazolinyl, thienopyrimidyl, pyrrolopyridyl, imidazopyridyl, isoquinolinyl, benzoazaindolyl, 1,2,4-triazinyl, and benzothiazolyl; and
“heterocyclyl” (or “heterocycloalkyl”) means a moiety selected from piperidyl, pyrrolidinyl, pyrazolidinyl, imidazolinyl, piperazinyl, morpholinyl, thiomorpholinyl, dithianyl, trithianyl, thiazolidinyl, 1,3-dioxolanyl, 1,4-dioxanyl, tetrahydrofuranyl, tetrahydrothiophenyl, and tetrahydrothiopyranyl.
2. The compound of claim 1 wherein R 2 is alkyl.
3. The compound of claim 2 wherein R 2 methyl.
4. The compound of claim 1 wherein R 3 is fluoro substituted phenylene.
5. The compound of claim 1 wherein R 4 is —C(O)-alkyl, alkyl, aryl, aralkyl, substituted aryl, substituted aralkyl, alkoxyalkyl, heteroaralkyl, substituted heteroaryl, substituted heteroaralkyl, alkoxyalkyl, heterocyclyl, heterocycylalkyl, substituted heterocyclyl, substituted heterocyclylalkyl or heteroaryl.
6. The compound of claim 5 wherein R 4 is methyl, ethyl, propyl, butyl, pentyl, hexyl, —C(O)Oethyl,
7. The compound of claim 1 wherein each R 7 is independently selected from hydrogen, alkyl substituted by a cycloalkyl group, alkyl substituted by an aryl and heteroaryl group.
8. The compound of claim 1 wherein X is a bond connecting R 3 and R 4 , or, alternatively, X is O, alkylene, -alkylene-NHSO 2 — or -alkylene-NHC(O)—.
9. The compound of claim 1 wherein
R 2 is alkyl;
R 3 is phenylene or halo-substituted phenylene;
R 4 is —C(O)-alkyl, alkyl, aryl, aralkyl, substituted aryl, substituted aralkyl, alkoxyalkyl, heteroaralkyl, substituted heteroaryl, substituted heteroaralkyl, alkoxyalkyl, heterocyclyl, heterocyclylalkyl, substituted heterocyclyl, substituted heterocyclylalkyl or heteroaryl;
each R 7 is independently selected from hydrogen, alkyl substituted by a cycloalkyl group, alkyl substituted by an aryl and heteroaryl group;
R 8 is
and
X is a bond connecting R 3 and R 4 , or, alternatively, X is O, alkylene, -alkylene-NHSO 2 — or -alkylene-NHC(O)—.
10. The compound of claim 9 wherein R 2 is methyl.
11. The compound of claim 9 wherein R 3 is
12. The compound of claim 9 wherein R 4 is methyl, ethyl, propyl, butyl, pentyl, hexyl, —C(O)Oethyl,
13. The compound of claim 9 wherein R 6 is
14. The compound of claim 9 wherein R 7 is hydrogen.
15. The compound of claim 9 wherein X is a bond connecting R 3 and R 4 , or, alternatively, X is O, alkylene, -alkylene-NHSO 2 — or -alkylene-NHC(O)—.
16. A compound of claim 1 having the stereochemical structure:
17. A compound, or a pharmaceutically acceptable salt thereof, said compound selected from the group consisting of
18. A pharmaceutical composition comprising a compound of claim 1 and a pharmaceutically effective carrier.
19. A compound of claim 1 in isolated or purified form.